You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

~ Buy the GATTEX KIT (teduglutide recombinant) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR GATTEX KIT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for gattex kit

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00072839 ↗ Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Completed Shire Phase 2 2003-11-12 The purpose of the study is to determine whether an investigational compound, ALX-0600, is safe and effective in treating Crohn's Disease.
NCT00081458 ↗ Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Completed Shire Phase 3 2004-05-25 The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of teduglutide compared with placebo in subjects with parenteral nutrition (PN)-dependent short bowel syndrome (SBS).
NCT00172185 ↗ Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458) Completed Shire Phase 3 2005-01-10 The purpose of this clinical study is to evaluate the long-term safety and efficacy of daily administration of teduglutide.
NCT00798967 ↗ Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects Completed Nycomed Phase 3 2008-11-25 Teduglutide is an investigative medicine being evaluated as a possible treatment for people with parenteral nutrition (PN) dependent Short Bowel Syndrome (SBS). Teduglutide is similar to a protein the body makes. When people have SBS, their bodies do not make enough of the protein and they have trouble getting nutrients and fluids from the food they eat and drink. This study was designed to provide evidence of efficacy, safety, and tolerability of teduglutide 0.05 mg/kg daily in SBS subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for gattex kit

Condition Name

Condition Name for gattex kit
Intervention Trials
Short Bowel Syndrome 6
Crohn's Disease 1
Hepatic Impairment 1
HIV 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for gattex kit
Intervention Trials
Short Bowel Syndrome 6
Syndrome 6
Crohn Disease 1
Intestinal Fistula 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for gattex kit

Trials by Country

Trials by Country for gattex kit
Location Trials
United States 57
Canada 13
Germany 6
United Kingdom 6
France 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for gattex kit
Location Trials
Pennsylvania 6
New York 6
Ohio 5
Georgia 5
Florida 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for gattex kit

Clinical Trial Phase

Clinical Trial Phase for gattex kit
Clinical Trial Phase Trials
Phase 4 1
Phase 3 6
Phase 2 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for gattex kit
Clinical Trial Phase Trials
Completed 11
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for gattex kit

Sponsor Name

Sponsor Name for gattex kit
Sponsor Trials
Shire 9
Massachusetts General Hospital 2
Takeda 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for gattex kit
Sponsor Trials
Industry 13
Other 7
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.